INGENION MEDICAL LIMITED

Active London

Other human health activities

8 employees website.com
Life sciences and medical technology Other human health activities
I

INGENION MEDICAL LIMITED

Other human health activities

Founded 27 Aug 2013 Active London, England 8 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 10 Mar 2026 Next due 28 Sept 2026 4 months remaining
Confirmation Submitted 17 May 2025 Next due 20 Apr 2026 29 days overdue
Net assets £2M £611K 2025 year on year
Total assets £3M £289K 2025 year on year
Total Liabilities £995K £322K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

101 New Cavendish Street 1st Floor South London W1W 6XH England

Email

info@example.com

Website

www.example.com

Full company profile for INGENION MEDICAL LIMITED (08664089), an active life sciences and medical technology company based in London, England. Incorporated 27 Aug 2013. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2014–2025)

Cash in Bank

£67.66k

Decreased by £423.08k (-86%)

Net Assets

£1.95M

Decreased by £611.09k (-24%)

Total Liabilities

£995.01k

Increased by £321.88k (+48%)

Turnover

N/A

Employees

8

Increased by 1 (+14%)

Debt Ratio

34%

Increased by 13 (+62%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 2

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

23 Allotments 52,033,340 Shares £5.47m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
12 Dec 20251,811,664£90.583£0
12 Dec 202545,167£5k£0.111
28 Apr 2025240,486£12.024£0
31 Jan 20251,333,103£267k£0.2
31 Dec 20242,650,000£530k£0.2

Officers

Officers

1 active 2 resigned
Status
Edward Charles CappabiancaDirectorAmerican,irishEngland6124 Feb 2020Active

Shareholders

Shareholders (78)

Sergio Rothstein
36.0%
27,340,048
The Katz 2021 Gift Trust
24.6%
18,663,829

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Barry Clare

British

Active
Notified 6 Apr 2016
Residence England
DOB June 1953
Nature of Control
  • Right To Appoint And Remove Directors

Mr Barry Clare

British

Active
Notified 6 Apr 2016
Residence England
DOB June 1953
Nature of Control
  • Right To Appoint And Remove Directors

Sergio Rothstein

American

Active
Notified 6 Apr 2016
Residence United States
DOB May 1943
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Mr Barry Clare

British

Active
Notified 6 Apr 2016
Residence England
DOB June 1953
Nature of Control
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026OfficersChange to director Mr Michael Ehrlich on 6 Apr 2026
27 Mar 2026Persons With Significant ControlChange to Mr Barry Clare as a person with significant control on 4 Jan 2026
27 Mar 2026OfficersChange to director Mr Barry Clare on 4 Jan 2026
10 Mar 2026AccountsAnnual accounts made up to 31 Dec 2025
9 Feb 2026CapitalAllotment of shares (GBP 3,902.69615) on 12 Dec 2025
14 Apr 2026 Officers

Change to director Mr Michael Ehrlich on 6 Apr 2026

27 Mar 2026 Persons With Significant Control

Change to Mr Barry Clare as a person with significant control on 4 Jan 2026

27 Mar 2026 Officers

Change to director Mr Barry Clare on 4 Jan 2026

10 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2025

9 Feb 2026 Capital

Allotment of shares (GBP 3,902.69615) on 12 Dec 2025

Recent Activity

Latest Activity

Change to director Mr Michael Ehrlich on 6 Apr 2026

1 months ago on 14 Apr 2026

Change to Mr Barry Clare as a person with significant control on 4 Jan 2026

1 months ago on 27 Mar 2026

Change to director Mr Barry Clare on 4 Jan 2026

1 months ago on 27 Mar 2026

Annual accounts made up to 31 Dec 2025

2 months ago on 10 Mar 2026

Allotment of shares (GBP 3,902.69615) on 12 Dec 2025

3 months ago on 9 Feb 2026